menu
    • menu
    [{"orgOrder":0,"company":"Provepharm Life Solutions","sponsor":"American Regent","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Small molecule","year":"2022","type":"Not Applicable","leadProduct":"Methylene Blue","moa":"Methemoglobin","graph1":"Hematology","graph2":"Approved","graph3":"Provepharm Life Solutions","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Injectable\/Injection","sponsorNew":"Provepharm Life Solutions \/ Provepharm Life Solutions","highestDevelopmentStatusID":"12","companyTruncated":"Provepharm Life Solutions \/ Provepharm Life Solutions"},{"orgOrder":0,"company":"Provepharm Life Solutions","sponsor":"Calyptus Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Large molecule","year":"2022","type":"Partnership","leadProduct":"Cetrorelix Acetate","moa":"","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Approved","graph3":"Provepharm Life Solutions","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Injectable\/Injection","sponsorNew":"Provepharm Life Solutions \/ Provepharm Life Solutions","highestDevelopmentStatusID":"12","companyTruncated":"Provepharm Life Solutions \/ Provepharm Life Solutions"}]

    Find Clinical Drug Pipeline Developments & Deals by Provence Technologies SAS

    Menu

    Provence Technologies SAS

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
    filter

    Year

    filter

    DEALS // DEV.

    filter

    Country

    filter
    Sponsor
    filter

    Therapeutic Area

    filter

    Study Phase

    filter

    Deal Type

    filter

    Product Type

    filter

    Dosage Form

    filter

    Lead Product

    filter

    Target

    refresh Filters
    refresh Reset Filter
    refresh Reset Filter
    price-trend All Developments

    Therapeutic Area by Lead Product

    ForexGraph

    Study Phase by Lead Product

    ForexGraph

    Company by Lead Product

    ForexGraph

    Top Deals by Deal Size (USD bn)

    ForexGraph

    01

    Provepharm Life Solutions

    France arrow
    BePharma
    Not Confirmed

    Provepharm Life Solutions

    France arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Cetrorelix Acetate

    Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

    Study Phase : Approved

    Recipient : Calyptus Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Calyptus Pharmaceuticals Announces Partnership with Provepharm to Accelerate Development of an Acute Care Inje...

    Details : Provepharm acquired global rights of the Cetrorelix acetate from Calyptus and will take on all development activities and ultimately commercial distribution upon approval.

    Product Name : Cetrorelix Acetate-Generic

    Product Type : Large molecule

    Upfront Cash : Undisclosed

    August 22, 2022

    Lead Product(s) : Cetrorelix Acetate

    Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

    Highest Development Status : Approved

    Recipient : Calyptus Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Partnership

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    02

    Provepharm Life Solutions

    France arrow
    BePharma
    Not Confirmed

    Provepharm Life Solutions

    France arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Methylene Blue

    Therapeutic Area : Hematology

    Study Phase : Approved

    Recipient : American Regent

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    American Regent Launches a New Vial Presentation

    Details : ProvayBlue (methylene blue) is hypotonic and may be diluted before use in a solution of 50 mL 5% Dextrose Injection in order to avoid local pain, particularly in the pediatric population. Use the diluted solution immediately after preparation.

    Product Name : ProvayBlue

    Product Type : Small molecule

    Upfront Cash : Not Applicable

    June 30, 2022

    Lead Product(s) : Methylene Blue

    Therapeutic Area : Hematology

    Highest Development Status : Approved

    Recipient : American Regent

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth